Connection

Ansgar Lohse to Hepatitis D

Back to Details
This is a "connection" page, showing publications Ansgar Lohse has written about Hepatitis D.
Ansgar Lohse
Connection Strength
0.571
Hepatitis D
  1. Detection of a Broad Range of Low-Level Major Histocompatibility Complex Class II-Restricted, Hepatitis Delta Virus (HDV)-Specific T-Cell Responses Regardless of Clinical Status. J Infect Dis. 2019 01 29; 219(4):568-577.
    View in: PubMed
    Score: 0.187
  2. Hepatitis delta virus persists during liver regeneration and is amplified through cell division both in vitro and in vivo. Gut. 2019 01; 68(1):150-157.
    View in: PubMed
    Score: 0.173
  3. Both interferon alpha and lambda can reduce all intrahepatic HDV infection markers in HBV/HDV infected humanized mice. Sci Rep. 2017 06 16; 7(1):3757.
    View in: PubMed
    Score: 0.167
  4. Time trend of reported cases and publications: hepatitis E in comparison to hepatitis A - D in Germany from 2001 to 2016. Z Gastroenterol. 2018 01; 56(1):29-35.
    View in: PubMed
    Score: 0.043
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.